1. Modulation of mTOR and epigenetic pathways as therapeutics in gallbladder cancer
    Dong Yang et al, 2021, Molecular Therapy - Oncolytics CrossRef
  2. Bacterial Lipopolysaccharide Augmented Malignant Transformation and Promoted the Stemness in Prostate Cancer Epithelial Cells
    Sijie Tang et al, 2021, Journal of Inflammation Research CrossRef
  3. Influence of Intra-Articular Administration of Trichostatin A on Autologous Osteochondral Transplantation in a Rabbit Model
    Huacheng Hou et al, 2015, BioMed Research International CrossRef
  4. 4-phenylbutyric acid promotes migration of gastric cancer cells by histone deacetylase inhibition-mediated IL-8 upregulation
    Xiaonan Shi et al, 2020, Epigenetics CrossRef
  5. Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer
    Sumin Oh et al, 2017, Translational Research in Breast Cancer CrossRef
  6. Valproic acid (VPA) inhibits the epithelial–mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4
    Xiaopeng Lan et al, 2016, Journal of Cancer Research and Clinical Oncology CrossRef
  7. Trichostatin A, an Inhibitor of Histone Deacetylase, Inhibits the Viability and Invasiveness of Hypoxic Rheumatoid Arthritis Fibroblast‐Like Synoviocytes via PI3K/Akt Signaling
    Yong Zhang et al, 2016, Journal of Biochemical and Molecular Toxicology CrossRef
  8. Pharmacological Properties of Trichostatin A, Focusing on the Anticancer Potential: A Comprehensive Review
    Abdelhakim Bouyahya et al, 2022, Pharmaceuticals CrossRef
  9. 4‐Phenybutyric acid promotes gastric cancer cell migration via histone deacetylase inhibition‐mediated HER3/HER4 up‐regulation
    Xiaonan Shi et al, 2018, Cell Biology International CrossRef
  10. Trichostatin A and Zebularine along with E-cadherin re-expression enhance tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cell cycle arrest in human breast adenocarcinoma cells
    Sonia How Ming Wong et al, 2021, Asia Pacific Journal of Molecular Biology and Biotechnology CrossRef
  11. miR-449a inhibits colorectal cancer progression by targeting SATB2
    Xiaohua Sun et al, 2017, Oncotarget CrossRef
  12. Short-term stimulation with histone deacetylase inhibitor trichostatin a induces epithelial-mesenchymal transition in nasopharyngeal carcinoma cells without increasing cell invasion ability
    Zhihua Shen et al, 2019, BMC Cancer CrossRef
  13. Epigenetic therapies: histone deacetylases
    Christophe Blanquart, 2023, Epigenetic Cancer Therapy CrossRef